Elevated cardiac specific troponin concentration in the absence of myocardial infarction. Part 2

DOI: https://doi.org/10.29296/25877305-2020-04-07
Download full text PDF
Issue: 
4
Year: 
2020

A. Chaulin(1, 2); L. Karslyan(1, 2), Candidate of Medical Sciences; A. Aleksandrov(3); D. Duplyakov(1, 2), MD (1)Samara Regional Clinical Cardiology Dispensary, Samara (2)Samara State Medical University (3)OOO «INVITRO-Samara», Samara

Part 2 of the review considers the mechanisms for the elevated cardiac isoforms of troponins and their diagnostic value during physical exercise, tachyarrhythmias, intake of cardiotoxic drugs (chemotherapy), cerebrovascular diseases, sepsis, skeletal myopathies, dissecting aortic aneurysm, and renal failure. In addition, it discusses the main factors causing a false-positive increase in the level of cardiac troponins: heterophile antibodies, rheumatoid factor, and alkaline phosphatase.

Keywords: 
cardiology
cardiac troponins
physical activity
sepsis
cardiotoxicity
stroke
dissecting aortic aneurysm
renal failure
glomerular filtration rate
false-positive results



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Roffi M., Patrono C., Collet J. et al. ESC Scientific Document Group. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardio-logy (ESC) // Eur. Heart J. – 2016; 37 (3): 267–315. https://doi.org/10.1093/eurheartj/ehv320
  2. Lim W., Qushmaq I., Devereaux P. et al. Elevated cardiac troponin measurements in critically ill patients // Arch. Intern. Med. – 2006; 166 (22): 2446–54. https://doi.org/10.1001/archinte.166.22.2446
  3. Richardson A., Leckie T., Watkins E. et al. Post marathon cardiac troponin T is associated with relative exercise intensity// J. Sci Med. Sport. – 2018; 21 (9): 880–4. https://doi.org/10.1016/j.jsams.2018.02.005
  4. Samaha E., Brown J., Brown F. et al. High-sensitive cardiac troponin T increases after stress echocardiography // Clin. Biochem. – 2019; 63: 18–23. https://doi.org/10.1016/j.clinbiochem.2018.11.013
  5. Manjunath L., Yeluru A., Rodriguez F. 27-Year-Old Man with a Positive Troponin: A Case Report // Cardiol. Ther. – 2018; 7 (2): 197–204. https://doi.org/10.1007/s40119-018-0120-3
  6. Bukkapatnam R., Robinson M., Turnipseed S. et al. Relationship of myocardial ischemia and injury to coronary artery disease in patients with supraventricular tachycardia // Am. J. Cardiol. – 2010; 106 (3): 374–7. DOI: 10.1016/j.amjcard.2010.03.035
  7. Ben Yedder N., Roux J., Paredes F. Troponin elevation in supraventricular tachycardia: primary dependence on heart rate // Can. J. Cardiol. – 2011; 27 (1): 105–9. DOI: 10.1016/j.cjca.2010.12.004.
  8. Kumar A., Paladugu B., Mensing J. et al. Transforming growth factor-beta 1 blocks in vitro cardiac myocyte depression induced by tumour necrosis factor-alpha, interleukin-1 beta, and human septic shock serum // Crit. Care Med. – 2007;35 (2): 358–64. DOI: 10.1097/01.CCM.0000254341.87098.A4
  9. Rosjo H., Varpula M., Hagve T. et al. Circulating high-sensitive troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome // Int. Care Med. – 2011; 37 (1): 77–85. https://doi.org/10.1007/s00134-010-2051-x
  10. Krikunova O.V., Vasjuk Ju.A., Viskov R.V. i dr. Serdechnye troponiny v vyjavlenii kardiotoksichnosti u patsientov, podvergajuschihsja himioterapii // Rossijskij kardiologicheskij zhurnal. – 2015; 20 (12): 119–25. [Krikunova O.V., Vasyuk Yu.A., Viskov R.V. et al. Chemotherapy cardiotoxicity screening with cardiac troponins // Rossiyskiy kardiologicheskiy zhurnal (Russian Journal of Cardiology). – 2015; 20 (12): 119–25 (in Russ.)]. https://doi.org/10.15829/1560-4071-2015-12-119-125
  11. Jones M., O’Gorman P., Kelly C. et al. High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury // Ann. Clin. Biochem. – 2017; 54 (1): 149–57. https://doi.org/10.1177/0004563216650464
  12. Jaffe A., Vasile V., Milone M. et al. Diseased skeletal muscle: a noncardiac sourse of increased circulating concentrations of cardiac troponin T // J. Am. Coll. Cardiol. – 2011; 58 (17): 1819–24. DOI: 10.1016/j.jacc.2011.08.026
  13. Rittoo D., Jones A., Lecky B. et al. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction // J. Am. Coll. Cardiol. – 2014; 63 (22): 2411–20. DOI: 10.1016/j.jacc.2014.03.027
  14. Schmid J., Liesinger L., Birner-Gruenberger R. et al. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies // J. Am. Coll. Cardiol. – 2018; 71 (14): 1540–9. DOI: 10.1016/j.jacc.2018.01.070
  15. Kerr G., Ray G., Wu O. et al. Elevated troponin after stroke: a systematic review // Cerebrovasc. Dis. – 2009; 28 (3): 220–6. DOI: 10.1159/000226773
  16. Barber M., Morton J., Macfarlane P. et al. Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke // Cerebrovasc. Dis. – 2007; 23 (4): 260–6. DOI: 10.1159/000098325
  17. Sandhu R., Aronow W., Rajdev A. et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage // Am. J. Cardiol. – 2008; 102 (5): 632–4. DOI: 10.1016/j.amjcard.2008.04.036.
  18. Ryden L., Roos A., Holzmann M. Chronic myocardial injury and risk for stroke // Am. J. Med. – 2019; 132 (7): 833–9. DOI: 10.1016/j.amjmed.2019.01.027
  19. Vrsalovic M. Prognostic effect of cardiac troponin elevation in acute aortic dissection: a meta-analysis // Int. J. Cardiol. – 2016; 214: 277– 80. DOI: 10.1016/j.ijcard.2016.03.230
  20. Chenevier-Gobeaux C., Meune C., Freund Y. et al. Influence of age and renal function on high-sensitivity cardiac troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction // Am. J. Cardiol. – 2013; 111 (12): 1701–7. https://doi.org/10.1016/j.amjcard.2013.02.024
  21. Dubin R., Li Y., He J. et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC) // BMC Nephrol. – 2013; 14: 229. https://doi.org/10.1186/1471-2369-14-229
  22. Ellis K., Dreisbach A., Lertora J. Plasma elimination of cardiac troponin I in end-stage renal disease // South. Med. J. – 2001; 94 (10): 993–6. https://doi.org/10.1097/00007611-200194100-00011
  23. Ziebig R., Lun A., Hocher B. et al. Renal elimination of troponin T and troponin I // Clin. Chem. – 2003; 49 (7): 1191–3. https://doi.org/10.1373/49.7.1191
  24. Pervan P., Svagusa T., Prkacin I. et al. Urine high-sensitive troponin I measuring in patients with hypertension // Signa Vitae. – 2017; 13 (3): 62–4. https://doi.org/10.22514/sv133.062017.13
  25. Freda B., Tang W., Van Lente F. et al. Cardiac troponins in renal insufficiency: review and clinical implications // J. Am. Coll. Cardiol. – 2002; 40 (12): 2065–71. https://doi.org/10.1016/s0735-1097(02)02608-6
  26. Antman E., Grudzien C., Mitchell R. et al. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T // Am. Heart J. – 1997; 133 (5): 596–8. https://doi.org/10.1016/s0002-8703(97)70156-x
  27. Ooi D., Isotalo P., Veinot J. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology // Clin. Chem. – 2000; 46 (3): 338–44.
  28. Ricchiutti V., Apple F. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle // Clin. Chem. – 1999; 45 (12): 2129–35. https://www.ncbi.nlm.nih.gov/pubmed/10585344
  29. Anderson P., Malouf N., Oakeley A. et al. Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle // Circ. Res. – 1991; 69 (5): 1226–33. https://doi.org/10.1161/01.res.69.5.1226
  30. Zumrutdal A., Bakinen O., Ucan H. et al. Relationship between uremic myopathy and false-positive cardiac troponin T test // Nephron. – 2000; 86 (4): 522–3. https://doi.org/10.1159/000045852
  31. Haller C., Zehelein J., Remppis A. et al. Cardiac troponin T in patients with end stage renal disease: Absence of expression in truncal skeletal muscle // Clin Chem. – 1998; 44 (5): 930–8. https://www.ncbi.nlm.nih.gov/pubmed/9590364
  32. Khan N., Hemmelgarn B., Tonelli M. et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis // Circulation. – 2005; 112 (20): 3088–96. https://doi.org/10.1161/circulationaha.105.560128
  33. Bjurman C., Petzold M., Venge P. et al. High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease // Clin. Biochem. – 2015; 48 (4–5): 302–7. https://doi.org/10.1016/j.clinbiochem.2015.01.008
  34. Twerenbold R., Wildi K., Jaeger C. et al. Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction // Circulation. – 2015; 131 (23): 2041–50. https://doi.org/10.1161/circulationaha.114.014245
  35. Kavsak P., Worster A., Shortt C. et al. Performance of high-sensitivity cardiac troponin in the emergency department for myocardial infarction and a composite cardiac outcome across different estimated glomerular filtration rates // Clin. Chim. Acta. – 2018; 479: 166–70. https://doi.org/10.1016/j.cca.2018.01.034
  36. Lippi G., Aloe R., Meschi T. et al. Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the literature // Clin. Chim. Acta. – 2013; 426: 79–84. doi: 10.1016/j.cca.2013.09.004
  37. Lum G., Solarz D., Farney L. False positive cardiac troponin results in patients without acute myocardial infarction // Laboratory Medicine. – 2006; 37 (9): 546–50. https://doi.org/10.1309/T94UUXTJ3TX5Y9W2
  38. Al-Awadhi A., Olusi S., Hasan E. et al. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren’s syndrome and Graves’ disease // Singapore Med. J. – 2007; 48 (9): 847–9. https://www.ncbi.nlm.nih.gov/pubmed/17728967
  39. Dasgupta A., Chow L., Wells A. et al. Effect of elevated concentration of alkaline phosphatase on cardiac troponin I assays // J. Clin. Lab. Anal. – 2001; 15 (4): 175–7. DOI: 10.1002/jcla.1023
  40. Marinheiro R., Amador P., Parreira L. et al. False Positive Troponin I Rendering Two Admissions for «Recurrent Acute Myopericarditis» // Open Cardiovasc. Med. J. – 2018; 12: 55–8. doi: 10.2174/1874192401812010055